Community Research and Development Information Service - CORDIS

Results 1 - 10 of 326
Order by: Results/page:
12 3 4 5 6 7 8 9 10 > >| 
Optimized Diagnostics for Improved Treatment Stratification in Invasive Fungal Diseases
ID: 602125
Start date: 2014-02-01, End date: 2019-01-31
Invasive fungal disease (IFD) is a leading cause of morbidity and mortality in the growing number of immunocompromised individuals, including particularly cancer patients, and bone-marrow or organ transplant recipients. The majority of IFD events are still caused by Candida a...
Programme: FP7-HEALTH
Record Number: 110939
Last updated on: 2017-04-24
Evaluation of phage therapy for the treatment of Escherichia coli and Pseudomonas aeruginosa burn wound infections (Phase I-II clinical trial)
ID: 601857
Start date: 2013-06-01, End date: 2017-02-28
Sepsis is the major problem of large burn patients and a predominant cause of death. The burn wound pathology, combined to a global intensive use of antibiotics (ATB), put patients at high risk of suffering from multidrug resistant (MDR) infections, notably carried out by the...
Programme: FP7-HEALTH
Record Number: 108695
Last updated on: 2017-04-24
A European Platform for Translational Cancer Research
ID: 260791
Start date: 2011-01-01, End date: 2016-12-31
Europe has a number of advantages as regards developing translational cancer research, yet there is no clear European strategy to meet the increasing burden posed by cancer. The FP6 Eurocan+Plus project analysed the barriers underlying the increasing fragmentation of cancer r...
Programme: FP7-HEALTH
Record Number: 97701
Last updated on: 2017-04-17
A systems biology approach to RESOLVE the molecular pathology of two hallmarks of patients with metabolic syndrome and its co-morbidities; hypertriglyceridemia and low HDL-cholesterol
ID: 305707
Start date: 2013-01-01, End date: 2018-06-30
Through combining basic pre-clinical and clinical research, network analysis and computational modelling, RESOLVE aims at resolving the disturbed dynamics and mechanisms underlying the high triglyceride (HTG) and low high-density lipoprotein cholesterol (HDL-C) phenotype and ...
Programme: FP7-HEALTH
Record Number: 106225
Last updated on: 2017-04-10
Development of an innovative paediatric formulation of an antiepileptic agent for the treatment of absence epilepsy in children
ID: 282559
Start date: 2011-10-01, End date: 2017-03-31
The KIEKIDS project is dedicated to the development of an innovative paediatric formulation of an antiepileptic agent for a safe alternative treatment of absence epilepsy in children. Development of such an age-appropriate formulation is regarded by The European Medicines Age...
Programme: FP7-HEALTH
Record Number: 100437
Last updated on: 2017-04-10
A BLUEPRINT of Haematopoietic Epigenomes
ID: 282510
Start date: 2011-10-01, End date: 2016-09-30
In response to the call for a high impact initiative on the human epigenome, the BLUEPRINT Consortium has been formed with the aim of generating at least 100 reference epigenomes and studying them to advance and exploit knowledge of the underlying biological processes and mec...
Programme: FP7-HEALTH
Record Number: 99677
Last updated on: 2017-04-10
Supporting sustainable participation of industry, in particular high-technology, research-intensive SMEs in EU-funded research in the Health Sector
ID: 602428
Start date: 2013-11-01, End date: 2017-10-31
Fit for Health 2.0 aims to promote and enhance a sustainable participation of European industry in the Health-related sector of Horizon 2020 (H2020). Focusing on research-intensive, high technology SMEs the project offers targeted support measures, covering the entire innovat...
Programme: FP7-HEALTH
Record Number: 109464
Last updated on: 2017-04-03
Development of very promising humanized therapeutic mAbs efficiently neutralizing a novel immunosuppressive pathway involved in a wide range of cancers
ID: 602200
Start date: 2013-09-01, End date: 2017-08-31
Studies have demonstrated the importance of CD73 in the spread of cancer. Overexpressed in numerous cancer types, this enzyme leads to the production of high amounts of extracellular Adenosine, creating an immunosuppressive microenvironment, and contributing to tumor prolifer...
Programme: FP7-HEALTH
Record Number: 110188
Last updated on: 2017-04-03
EPIGENETICS FOR FEMALE PERSONALIZED CANCER CARE
ID: 305428
Start date: 2012-11-01, End date: 2016-04-30
CLINICAL NEED Every year in the EU ~45,300 and 330,000 women are diagnosed with ovarian and breast cancer respectively & 28,800 and 90,000 of these two groups of women will die as a consequence of these diseases. Currently there are no tools available that allow for: a) Effec...
Programme: FP7-HEALTH
Record Number: 105712
Last updated on: 2017-03-27
European Collaborative Project on Inflamation and Vascular Wall Remodelling in Atherosclerosis
ID: 201668
Start date: 2008-05-01, End date: 2013-10-31
The health of the EC population has never been better. However, serious public health problems remain, which cannot be ignored including high levels of premature death due to cardiovascular diseases. Thus, new preventive, diagnostic and therapeutic strategies against atherosc...
Programme: FP7-HEALTH
Record Number: 88216
Last updated on: 2017-03-27
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2017-04-27
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top